Syncom Formulation (India) Ltd. (IN:SYNCOMF)
:SYNCOMF
Want to see IN:SYNCOMF full AI Analyst Report?
SYNCOMF Stock Chart & Stats
₹13.98
-₹0.26(-1.33%)
At close: 4:00 PM EST
₹13.98
-₹0.26(-1.33%)
Day’s Range― - ―
52-Week Range₹10.21 - ₹19.99
Previous CloseN/A
Volume2.15M
Average Volume (3M)249.72K
Market Cap
₹13.14B
Enterprise Value₹13.32B
Total Cash (Recent Filing)₹1.45B
Total Debt (Recent Filing)₹6.97M
Price to Earnings (P/E)17.1
Beta1.59
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.69
Shares Outstanding940,000,000
10 Day Avg. Volume232,913
30 Day Avg. Volume249,719
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)2.34
Price to Sales (P/S)1.99
P/FCF Ratio21.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthThe company cut gross debt dramatically and expanded equity (~₹4.15B), producing extremely low leverage (debt-to-equity ~0.004). This durable de-risking reduces refinancing and solvency risk, improves financial flexibility for capex, R&D or M&A, and raises resilience to industry cycles.
Improved ProfitabilityNet margin expanded materially to ~15.6% while operating margins stayed in a ~14–16% band, signaling stronger earnings power and operational leverage. Sustained margins would boost internal funding capacity, improve ROIC, and provide a structural buffer against input cost volatility.
Free Cash Flow RecoveryFY2026 showed a meaningful cash-flow rebound with OCF and FCF covering a large portion of profits (FCF ~79% of net income). Strong free cash flow supports durable internal funding for working capital, reinvestment or debt reduction, reducing dependence on external financing.
Bears Say
Revenue DeclineTop-line fell about 5% in FY2026 after prior scale-up, suggesting demand softness or contract attrition. A shrinking revenue base can limit the durability of margin improvements, weaken scale economics, and constrain reinvestment unless growth stabilizes or new channels/products emerge.
Gross Margin CompressionGross margin narrowed substantially year-over-year, implying adverse mix shifts or higher input costs. Persistent margin erosion would reduce operating leverage and make it harder to sustain recent profit improvements without pricing power, cost controls, or a shift to higher-margin products.
Cash-Flow VolatilityHistorical volatility—negative OCF/FCF in FY2023–FY2024 and uneven cash conversion—means cash generation is not consistently reliable. Even with FY2026’s rebound, this variability raises the risk that the company could need external funding during downturns, undermining planning certainty.
Syncom Formulation (India) Ltd. News
SYNCOMF FAQ
What was Syncom Formulation (India) Ltd.’s price range in the past 12 months?
Syncom Formulation (India) Ltd. lowest stock price was ₹10.21 and its highest was ₹19.99 in the past 12 months.
What is Syncom Formulation (India) Ltd.’s market cap?
Syncom Formulation (India) Ltd.’s market cap is ₹13.14B.
When is Syncom Formulation (India) Ltd.’s upcoming earnings report date?
Syncom Formulation (India) Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 49 days.
How were Syncom Formulation (India) Ltd.’s earnings last quarter?
Syncom Formulation (India) Ltd. released its earnings results on May 22, 2026. The company reported ₹0.27 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.27.
Is Syncom Formulation (India) Ltd. overvalued?
According to Wall Street analysts Syncom Formulation (India) Ltd.’s price is currently Overvalued.
Does Syncom Formulation (India) Ltd. pay dividends?
Syncom Formulation (India) Ltd. pays a Notavailable dividend of ₹0.03 which represents an annual dividend yield of N/A. See more information on Syncom Formulation (India) Ltd. dividends here
What is Syncom Formulation (India) Ltd.’s EPS estimate?
Syncom Formulation (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncom Formulation (India) Ltd. have?
Syncom Formulation (India) Ltd. has 940,000,000 shares outstanding.
What happened to Syncom Formulation (India) Ltd.’s price movement after its last earnings report?
Syncom Formulation (India) Ltd. reported an EPS of ₹0.27 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.42%.
Which hedge fund is a major shareholder of Syncom Formulation (India) Ltd.?
Currently, no hedge funds are holding shares in IN:SYNCOMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syncom Formulation (India) Ltd.
Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.
Technical Analysis
GRP Ltd
―
Knowledge Marine & Engineering Works Limited
―
Media Matrix Worldwide Limited
―
Updater Services Limited
―
Uniparts India Ltd.
―